Time to incorporate time in cost-effectiveness analysis

被引:16
|
作者
van de Wetering, Gijs [1 ]
Woertman, Willem H. [1 ]
Adang, Eddy M. [1 ]
机构
[1] Radboud Univ Nijmegen, Dept Epidemiol Biostat & HTA, Med Ctr, NL-6500 HB Nijmegen, Netherlands
来源
EUROPEAN JOURNAL OF HEALTH ECONOMICS | 2012年 / 13卷 / 03期
关键词
Time; Economic evaluation; Short run; Cost-effectiveness; DECISION-MAKING; ECONOMIC-EVALUATION; CARE;
D O I
10.1007/s10198-011-0374-3
中图分类号
F [经济];
学科分类号
02 ;
摘要
Cost-effectiveness analysis as a means to evaluate medical innovations has become well accepted in the UK and several other Western countries. An important assumption underlying this method is that costs and effects are constant over time. In reality, however, and especially in the short run, variations in costs and effects are likely to occur. These variations can lead to considerable deviations from the outcome of a conventional economic evaluation, which in turn may lead to serious implementation problems at a local level. Taking time into account explicitly in economic evaluations in health care may enhance their utility for both societal and local decision making, and may ultimately smooth the adoption of new and basically cost-effective health care technologies.
引用
收藏
页码:223 / 226
页数:4
相关论文
共 50 条
  • [31] Impact of Socioeconomic Differences on Distributional Cost-effectiveness Analysis
    Yang, Fan
    Angus, Colin
    Duarte, Ana
    Gillespie, Duncan
    Walker, Simon
    Griffin, Susan
    MEDICAL DECISION MAKING, 2020, 40 (05) : 606 - 618
  • [32] Buprenorphine versus methadone maintenance: a cost-effectiveness analysis
    Doran, CM
    Shanahan, M
    Mattick, RP
    Ali, R
    White, J
    Bell, J
    DRUG AND ALCOHOL DEPENDENCE, 2003, 71 (03) : 295 - 302
  • [33] The cost-effectiveness of a real-time seizure detection application for people with epilepsy
    Cai, Yiying
    Chang, Kevin
    Nazeha, Nuraini
    Gosavi, Tushar Divakar
    Shen, Jia Yi
    Hong, Weiwei
    Tan, Yee-Leng
    Graves, Nicholas
    EPILEPSY & BEHAVIOR, 2023, 148
  • [34] Real-World Cost-Effectiveness Analysis: How Much Uncertainty Is in the Results?
    Barr, Heather K.
    Guggenbickler, Andrea M.
    Hoch, Jeffrey S.
    Dewa, Carolyn S.
    CURRENT ONCOLOGY, 2023, 30 (04) : 4078 - 4093
  • [35] Cost-Effectiveness of Reduced Waiting Time for Head and Neck Cancer Patients due to a Lean Process Redesign
    Simons, Pascale A. M.
    Ramaekers, Bram
    Hoebers, Frank
    Kross, Kenneth W.
    Marneffe, Wim
    Pijls-Johannesma, Madelon
    Vandijck, Dominique
    VALUE IN HEALTH, 2015, 18 (05) : 587 - 596
  • [36] Cost-effectiveness in health in Brazil: a systematic review
    Moraz, Gabriele
    Garcez, Anderson da Silva
    de Assis, Eliseu Miranda
    dos Santos, Jandira Pereira
    Barcellos, Nemora Tregnago
    Kroeff, Locimara Ramos
    CIENCIA & SAUDE COLETIVA, 2015, 20 (10): : 3211 - 3229
  • [37] Cost-effectiveness of the Victorian Stroke Telemedicine program
    Kim, Joosup
    Tan, Elise
    Gao, Lan
    Moodie, Marj
    Dewey, Helen M.
    Bagot, Kathleen L.
    Pompeani, Nancy
    Sheppard, Lauren
    Bladin, Christopher F.
    Cadilhac, Dominique A.
    AUSTRALIAN HEALTH REVIEW, 2022, 46 (03) : 294 - 301
  • [38] Cost-effectiveness of somatostatin analogues in the treatment of acromegaly
    Orlewska, Ewa
    Stepien, Renata
    Orlewska, Katarzyna
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2019, 19 (01) : 15 - 25
  • [39] Distributional Cost-Effectiveness Analysis: A Tutorial
    Asaria, Miqdad
    Griffin, Susan
    Cookson, Richard
    MEDICAL DECISION MAKING, 2016, 36 (01) : 8 - 19
  • [40] Estimating ‘Costs’ for Cost-Effectiveness Analysis
    Alec Miners
    PharmacoEconomics, 2008, 26 : 745 - 751